Measles and atopy in Guinea-Bissau. 1996

S O Shaheen, and P Aaby, and A J Hall, and D J Barker, and C B Heyes, and A W Shiell, and A Goudiaby
Medical Research Council Environmental Epidemiology Unit, University of Southampton, Southhampton General Hospital, UK.

BACKGROUND Epidemiological studies have led to speculation that infections in early childhood may prevent allergic sensitisation but evidence to support this hypothesis is lacking. We investigated whether measles infection protects against the development of atopy in children of Guinea-Bissau, West Africa. METHODS We conducted a historical cohort study in Bandim, a semi-rural district of Bissau, the capital of Guinea-Bissau. 395 young adults, first surveyed in 1978-80 aged 0-6 years, were followed up in 1994. Our analyses were restricted to 262 individuals still living in Bandim for whom a measles history, documented in childhood, was judged to be reliable. We defined atopy as skin-prick test positivity (> or = 3 mm weal) to one or more of seven allergens. RESULTS 17 (12.8 percent) of 133 participants who had had measles infection were atopic compared with 33 (25.6 percent) of 129 of those who had been vaccinated and not had measles (odds ratio, adjusted for potential confounding variables 0.36 [95 percent CI 0.17-0.78], p=O.O1). Participants who had been breastfed for more than a year were less likely to have a positive skin test to housedust mite. After adjustment for breastfeeding and other variables, measles infection was associated with a large reduction in the risk of skin-prick test positivity to housedust mite (odds ratio for Dermatophagoides pteronyssinus 0.20 [0.05-0.81], p=0.02; D farinae 0.20 [0.06-0.71], p=0.01). CONCLUSIONS Measles infection may prevent the development of atopy in African children.

UI MeSH Term Description Entries
D006969 Hypersensitivity, Immediate Hypersensitivity reactions which occur within minutes of exposure to challenging antigen due to the release of histamine which follows the antigen-antibody reaction and causes smooth muscle contraction and increased vascular permeability. Atopic Hypersensitivity,Hypersensitivity, Atopic,Hypersensitivity, Type I,IgE-Mediated Hypersensitivity,Type I Hypersensitivity,Atopic Hypersensitivities,Hypersensitivities, Atopic,Hypersensitivities, IgE-Mediated,Hypersensitivities, Immediate,Hypersensitivities, Type I,Hypersensitivity, IgE-Mediated,IgE Mediated Hypersensitivity,IgE-Mediated Hypersensitivities,Immediate Hypersensitivities,Immediate Hypersensitivity,Type I Hypersensitivities
D007223 Infant A child between 1 and 23 months of age. Infants
D008297 Male Males
D008457 Measles A highly contagious infectious disease caused by MORBILLIVIRUS, common among children but also seen in the nonimmune of any age, in which the virus enters the respiratory tract via droplet nuclei and multiplies in the epithelial cells, spreading throughout the MONONUCLEAR PHAGOCYTE SYSTEM. Rubeola
D008458 Measles Vaccine A live attenuated virus vaccine of chick embryo origin, used for routine immunization of children and for immunization of adolescents and adults who have not had measles or been immunized with live measles vaccine and have no serum antibodies against measles. Children are usually immunized with measles-mumps-rubella combination vaccine. (From Dorland, 28th ed) Vaccine, Measles
D001942 Breast Feeding The nursing of an infant at the breast. Breast Fed,Breastfed,Milk Sharing,Wet Nursing,Breast Feeding, Exclusive,Breastfeeding,Breastfeeding, Exclusive,Exclusive Breast Feeding,Exclusive Breastfeeding,Sharing, Milk
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup

Related Publications

S O Shaheen, and P Aaby, and A J Hall, and D J Barker, and C B Heyes, and A W Shiell, and A Goudiaby
November 1981, Lancet (London, England),
S O Shaheen, and P Aaby, and A J Hall, and D J Barker, and C B Heyes, and A W Shiell, and A Goudiaby
December 1983, Annals of tropical paediatrics,
S O Shaheen, and P Aaby, and A J Hall, and D J Barker, and C B Heyes, and A W Shiell, and A Goudiaby
October 1998, Lancet (London, England),
S O Shaheen, and P Aaby, and A J Hall, and D J Barker, and C B Heyes, and A W Shiell, and A Goudiaby
January 2017, Tropical medicine & international health : TM & IH,
S O Shaheen, and P Aaby, and A J Hall, and D J Barker, and C B Heyes, and A W Shiell, and A Goudiaby
January 1984, The Journal of infection,
S O Shaheen, and P Aaby, and A J Hall, and D J Barker, and C B Heyes, and A W Shiell, and A Goudiaby
January 2017, Global health action,
S O Shaheen, and P Aaby, and A J Hall, and D J Barker, and C B Heyes, and A W Shiell, and A Goudiaby
January 1996, Jeune Afrique (Paris, France : 1980),
S O Shaheen, and P Aaby, and A J Hall, and D J Barker, and C B Heyes, and A W Shiell, and A Goudiaby
February 1989, Department of State publication. Background notes series,
S O Shaheen, and P Aaby, and A J Hall, and D J Barker, and C B Heyes, and A W Shiell, and A Goudiaby
April 1985, Department of State publication. Background notes series,
S O Shaheen, and P Aaby, and A J Hall, and D J Barker, and C B Heyes, and A W Shiell, and A Goudiaby
November 1986, The Journal of infectious diseases,
Copied contents to your clipboard!